[go: up one dir, main page]

AU2970595A - Inhibition of virus by nitric oxide - Google Patents

Inhibition of virus by nitric oxide

Info

Publication number
AU2970595A
AU2970595A AU29705/95A AU2970595A AU2970595A AU 2970595 A AU2970595 A AU 2970595A AU 29705/95 A AU29705/95 A AU 29705/95A AU 2970595 A AU2970595 A AU 2970595A AU 2970595 A AU2970595 A AU 2970595A
Authority
AU
Australia
Prior art keywords
virus
inhibition
nitric oxide
nitric
oxide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU29705/95A
Inventor
Joan Mannick
Jonathan Stamler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Brigham and Womens Hospital Inc
Original Assignee
Brigham and Womens Hospital Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brigham and Womens Hospital Inc filed Critical Brigham and Womens Hospital Inc
Publication of AU2970595A publication Critical patent/AU2970595A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A61K38/063—Glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Zoology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU29705/95A 1994-07-15 1995-07-13 Inhibition of virus by nitric oxide Abandoned AU2970595A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27605794A 1994-07-15 1994-07-15
PCT/US1995/008763 WO1996002268A1 (en) 1994-07-15 1995-07-13 Inhibition of virus by nitric oxide
US276057 1999-03-25

Publications (1)

Publication Number Publication Date
AU2970595A true AU2970595A (en) 1996-02-16

Family

ID=23054966

Family Applications (1)

Application Number Title Priority Date Filing Date
AU29705/95A Abandoned AU2970595A (en) 1994-07-15 1995-07-13 Inhibition of virus by nitric oxide

Country Status (2)

Country Link
AU (1) AU2970595A (en)
WO (1) WO1996002268A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6709681B2 (en) 1995-02-17 2004-03-23 Aberdeen University Acidified nitrite as an antimicrobial agent
US6232434B1 (en) 1996-08-02 2001-05-15 Duke University Medical Center Polymers for delivering nitric oxide in vivo
WO2003018102A2 (en) 2001-08-29 2003-03-06 Vectura Limited Topical administration device
DE10303196A1 (en) * 2003-01-28 2004-08-12 Märtz, Hans Helmut Use of products that release nitric oxide in vivo to treat or prevent infectious diseases in humans or animals
SE0300971D0 (en) * 2003-04-03 2003-04-03 Aga Ab Nitric oxide in the treatment of inflammation
WO2006127482A1 (en) * 2005-05-20 2006-11-30 Bioenvision, Inc. Methylene blue therapy of viral disease
US9393233B2 (en) * 2005-08-17 2016-07-19 Rush University Medical Center Vector delivery-based microbicides
WO2010017633A1 (en) * 2008-08-13 2010-02-18 Chris Miller Use of nitric oxide
CN116327965B (en) * 2023-02-09 2025-09-26 中山大学·深圳 Preparation method and application of composite hydrogel based on bioadhesive nanoparticles

Also Published As

Publication number Publication date
WO1996002268A1 (en) 1996-02-01

Similar Documents

Publication Publication Date Title
AU2018995A (en) Process for the purification of nitric oxide
AU2339295A (en) Process for the purification of nitric oxide
AU7819994A (en) Nitric oxide treatment
AU5749196A (en) N-nitroso-n-substituted hydroxylamines as nitric oxide donor s
AU4794593A (en) Antisense viruses and antisense-ribozyme viruses
AU3201095A (en) Substituted thiazoles for the treatment of inflammation
AU2045192A (en) Compounds and methods for inhibition of hiv and related viruses
AU7045194A (en) Compounds which release nitric oxide
AU4515896A (en) Substituted 2-acylamino-pyridines as inhibitors of nitric oxide synthase
AU3095095A (en) Rna component of telomerase
AU4287096A (en) Oral compositions of h2-antagonists
AU2907697A (en) Decontamination of metal
AU2424895A (en) Substituted spirodienes for the treatment of inflammation
AU8011194A (en) Compounds, compositions and treatment of allergies and inflammation
AU7957894A (en) Compounds, compositions and treatment of allergies and inflammation therewith
AU2970595A (en) Inhibition of virus by nitric oxide
AU3959393A (en) Improvements relating to the protection of corrosion-susceptible members
AU4134996A (en) Method of inhibiting nitric oxide formation
AU4348493A (en) Inhaler
AU6528494A (en) Nitric oxide combination therapy
AU4032793A (en) Nitric oxide sensor
AU7212694A (en) Inhibition of human immunodeficiency virus reproduction by deoxyribonuclease i
AU6927894A (en) 4-amidinophenylsulphonamides for the treatment of thrombo-embolitic conditions
AU4276496A (en) 3-Thioheteroaryl cephalosporin compounds, compositions and methods of use
AU5526196A (en) Compositions for the treatment of dandruff